|
|
inflammatory response
|
GO:0006954 |
244 |
0.432
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.372
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.333
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.328
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.288
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.247
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.246
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.216
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.208
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.201
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.194
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.190
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.188
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.185
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.185
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.178
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.169
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.169
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.169
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.165
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.156
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.148
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.145
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.144
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.141
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.141
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.141
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.140
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.138
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.137
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.136
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.133
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.131
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.128
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.127
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.127
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.126
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.125
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.123
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.120
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.119
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.118
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.117
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.116
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.116
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.113
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.113
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.113
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.111
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.111
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.111
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.110
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.110
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.109
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.109
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.106
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.105
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.105
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.102
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.101
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.100
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.100
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.099
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.098
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.096
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.096
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.094
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.093
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.093
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.091
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.089
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.089
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.089
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.085
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.085
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.085
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.084
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.083
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.083
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.082
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.082
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.080
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.080
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.080
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.079
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.078
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.078
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.078
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.077
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.077
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.077
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.076
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.076
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.076
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.076
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.075
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.074
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.074
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.074
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.074
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.074
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.074
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.073
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.073
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.073
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.073
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.072
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.072
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.072
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.072
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.072
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.071
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.071
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.071
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.070
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.070
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.070
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.070
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.069
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.069
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.068
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.068
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.068
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.068
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.067
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.067
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.067
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.066
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.066
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.066
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.065
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.064
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.064
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.063
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.063
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.063
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.063
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.062
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.062
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.062
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.061
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.061
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.061
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.061
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.061
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.061
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.060
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.060
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.060
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.059
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.058
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.058
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.058
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.057
|
Mouse |
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.057
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.056
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.056
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.056
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.056
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.055
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.054
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.053
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.053
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.053
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.052
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.052
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.052
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.052
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.052
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.051
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.051
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.051
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.050
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.050
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.050
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.049
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.049
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.049
|
Mouse |
|
|
organ growth
|
GO:0035265 |
117 |
0.049
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.048
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.048
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.048
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.048
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.048
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.048
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.048
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.048
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.047
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.047
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.047
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.047
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.047
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.046
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.046
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.046
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.046
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.046
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.046
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.046
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.046
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.046
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.045
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.045
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.045
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.044
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.044
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.044
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.044
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.044
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.044
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.044
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.044
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.043
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.043
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.043
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.043
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.043
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.043
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.043
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.042
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.042
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.042
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.042
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.042
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.042
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.041
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.041
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.041
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.041
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.041
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.041
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.040
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.040
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.040
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.040
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.040
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.040
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.040
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.040
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.040
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.039
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.039
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.039
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.039
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.039
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.039
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.038
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.038
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.038
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.038
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.038
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.037
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.037
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.037
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.037
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.037
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.037
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.037
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.037
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.037
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.037
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.036
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.036
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.036
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.036
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.036
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.036
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.036
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.036
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.035
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.035
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.035
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.035
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.035
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.035
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.035
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.035
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.035
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.035
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.035
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.034
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.034
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.034
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.034
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.034
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.034
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.034
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.034
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.034
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.033
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.033
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.033
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.033
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.033
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.033
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.033
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.033
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.033
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.033
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.032
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.032
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.032
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.032
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.032
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.032
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.032
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.032
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.031
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.031
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.031
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.031
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.031
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.031
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.031
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.031
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.031
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.031
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.031
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.030
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.030
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.030
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.030
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.030
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.030
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.030
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.030
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.030
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.030
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.030
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.030
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.030
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.030
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.030
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.030
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.030
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.030
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.029
|
|
|
|
renal capsule specification
|
GO:0072130 |
1 |
0.029
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.029
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.029
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.029
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.029
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.029
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.029
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.029
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.029
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.029
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.029
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.029
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.029
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.028
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.028
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.028
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.028
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.028
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.028
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.028
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.028
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.028
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.028
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.028
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.028
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.027
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.027
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.027
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.027
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.027
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.027
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.027
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.027
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.027
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.026
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.026
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.026
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.026
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.026
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.026
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.026
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.026
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.025
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.025
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.025
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.025
|
|
|
|
general adaptation syndrome behavioral process
|
GO:0051867 |
1 |
0.025
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.025
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.025
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.025
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.025
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.025
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.025
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.025
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.025
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.025
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.025
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.025
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.025
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.025
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.024
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.024
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.024
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.024
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.024
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.024
|
|
|
|
regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010578 |
3 |
0.024
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.024
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.024
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.024
|
Mouse |
|
|
renal tubule development
|
GO:0061326 |
87 |
0.024
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.024
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.024
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.024
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.024
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.024
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.024
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.024
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.024
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.023
|
Mouse |
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.023
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.023
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.023
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.023
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.023
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.023
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.023
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.023
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.023
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.023
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.023
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.022
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.022
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.022
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.022
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.022
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.022
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.022
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.022
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.022
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.022
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.022
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.021
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.021
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.021
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.021
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
Mouse |
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.021
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.021
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.021
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.021
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.021
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.021
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.021
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.021
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.021
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.020
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.020
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.020
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.020
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.020
|
|
